Skip to main content
SRx Health Solutions, Inc. logo

SRx Health Solutions, Inc. — Investor Relations & Filings

Ticker · SRXH ISIN · US08771Y3036 US Human health and social work activities
Open in API
Filings indexed 523 across all filing types
Latest filing 2026-04-22 Regulatory Filings
Country US United States of America
Listing US SRXH

About SRx Health Solutions, Inc.

https://srxhealth.com/

SRx Health Solutions, Inc. is an integrated healthcare services provider operating within the specialty healthcare industry. The company focuses on enhancing well-being for both people and pets. Its core services for humans include specialty pharmacy, managing complex medication regimens in collaboration with hospitals and physicians to improve patient outcomes. It also offers wholesale, distribution, and clinical trial support services. Additionally, the company provides a range of animal health and wellness products, including food and supplements for dogs and cats, blending its specialty healthcare expertise with pet nutrition.

Recent filings

Filing Released Lang Actions
8-K - SRx Health Solutions, Inc. (0001471727) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It reports a specific event: an investment by a subsidiary that exceeds 10% of the company's treasury assets. The document includes a press release as an exhibit and is signed by the CFO. The length is 3938 characters, which is relatively short and typical for an 8-K filing. Form 8-K filings are current reports used to announce major events that shareholders should know about, but they are not annual or quarterly reports, nor are they earnings releases or management discussions. This fits the category of Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories. Therefore, the correct classification is Regulatory Filings (RNS).
2026-04-22 English
8-K - SRx Health Solutions, Inc. (0001471727) (Filer)
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. It includes a press release updating stockholders on a transaction progress and contains forward-looking statements. The document does not contain comprehensive financial statements or detailed financial analysis but serves as a timely disclosure of a material event. Form 8-K filings are generally classified as Regulatory Filings (RNS) because they are regulatory announcements of material events rather than full financial reports or other specific filings.
2026-04-17 English
S-4 - SRx Health Solutions, Inc. (0001471727) (Filer)
Merger & Acquisition Classification · 95% confidence The document is a Form S-4 Registration Statement filed with the SEC, dated April 14, 2026, by SRx Health Solutions, Inc. It is a detailed prospectus/information statement related to a proposed transaction involving issuance of common stock as consideration for an acquisition. The document includes detailed information about the transaction, risk factors, management discussion and analysis, pro forma financial information, director and executive officer information, stock ownership, tax consequences, related party transactions, and other disclosures typical of a merger/acquisition filing. The presence of a Share Exchange and Asset Transfer Agreement as an annex and the focus on the transaction and issuance of shares in connection with an acquisition clearly indicate this is related to merger and acquisition activity. The form type S-4 is specifically used for securities registration in connection with mergers and acquisitions. Therefore, the appropriate classification is Merger & Acquisition (MA). The document length (15,000 characters) and content confirm it is the actual filing, not just an announcement or proxy solicitation. Hence, the classification is MA with high confidence.
2026-04-14 English
8-K - SRx Health Solutions, Inc. (0001471727) (Filer)
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, titled 'Current Report' and dated March 16, 2026. It details the entry into a material definitive agreement, specifically a Securities Purchase Agreement for a private placement of Series B convertible preferred stock and warrants. The content focuses on the terms of the private placement, rights and preferences of the Series B Preferred Stock, and related registration rights. There are no financial statements or comprehensive financial data presented, nor is this an earnings release or annual/interim report. The document is a regulatory announcement of a material event related to financing activities. According to the filing definitions, updates on company fundraising and capital structure changes fall under 'Capital/Financing Update (CAP)'. Therefore, this document is best classified as a Capital/Financing Update (CAP). The document length and detail support a high confidence level.
2026-03-18 English
8-K - SRX HEALTH SOLUTIONS, INC. (0001471727) (Filer)
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It details the entry into a material definitive agreement related to securities purchase agreements and financing activities, including issuance of convertible notes, preferred stock, and warrants. The content focuses on financing transactions and agreements rather than full financial statements or earnings results. The document length is 7944 characters, which is sufficient for substantive content. Given the focus on financing activities and capital raising, the appropriate classification is Capital/Financing Update (CAP).
2026-03-03 English
8-K - SRX HEALTH SOLUTIONS, INC. (0001471727) (Filer)
Delisting Announcement Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report pursuant to the Securities Exchange Act of 1934. It details a specific event: the receipt of a warning letter from the NYSE regarding non-compliance with listing rules related to share issuance and stockholder approval. The document includes descriptions of the event, references to prior filings, and attached exhibits such as the warning letter and a press release. There are no financial statements or comprehensive financial data presented, nor is this an earnings release or annual/interim report. The content is focused on a regulatory compliance issue and a delisting-related notice. Therefore, the most appropriate classification is a Delisting Announcement (DLST). The document length (6659 characters) supports it being a full report rather than a brief announcement or certification. Confidence is high given the clear identification of the filing type and content.
2026-02-20 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.